Precision Oncology .

About

Precision Oncology is dedicated to improving cancer care through precision oncology technologies. Their main product is a research use only (RUO) targeted methylation platform, launched in 2023. This platform uses customizable machine learning algorithms to analyze circulating cell-free DNA (cfDNA) from blood samples, allowing for the estimation of tumor burden and enabling ongoing monitoring of cancer patients. The company is developing a range of precision oncology solutions aimed at enhancing cancer diagnosis, treatment, and monitoring. Their technology supports various applications, including risk stratification, disease classification, and clinical monitoring. Precision Oncology collaborates with leading oncology firms to explore biomarker applications that optimize therapeutic interventions, focusing on clinical studies and companion diagnostics.